COVID-19 pandemic-related healthcare interruptions and diabetes distress: a national study of US adults with diabetes
- PMID: 38365654
- PMCID: PMC10870610
- DOI: 10.1186/s12889-024-17921-3
COVID-19 pandemic-related healthcare interruptions and diabetes distress: a national study of US adults with diabetes
Abstract
Background: Early COVID-19 pandemic research found changes in health care and diabetes management, as well as increased diabetes distress. This study aims to determine the association between COVID-19 pandemic-related healthcare interruptions and diabetes distress among adults with Type 1 and Type 2 diabetes in the US in 2021.
Methods: Multinomial logistic regression was used to analyze moderate and high levels of diabetes distress (reference = no diabetes distress) in 228 individuals with Type 1 diabetes and 2534 individuals with Type 2 diabetes interviewed in the National Health Interview Survey in 2021.
Results: Among adults with Type 1 diabetes, 41.2% experienced moderate diabetes distress and 19.1% experienced high diabetes distress, and among adults with Type 2 diabetes, 40.8% experienced moderate diabetes distress and 10.0% experienced high diabetes distress. In adults with Type 1 diabetes, experiencing delayed medical care was associated with an adjusted odds ratio (aOR) of 4.31 (95% CI: 1.91-9.72) for moderate diabetes distress and 3.69 (95% CI: 1.20-11.30) for high diabetes distress. In adults with Type 2 diabetes, experiencing delayed medical care was associated with an aOR of 1.61 (95% CI: 1.25-2.07) for moderate diabetes distress and 2.27 (95% CI: 1.48-3.49) for high diabetes distress. Similar associations were observed between not receiving medical care due to the pandemic and diabetes distress.
Conclusion: Among people with diabetes, experiencing delayed medical care and not receiving care due to the pandemic were associated with higher reports of diabetes distress.
Keywords: COVID-19 pandemic; Diabetes distress; Type 1 diabetes; Type 2 diabetes.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.J Diabetes Sci Technol. 2021 Sep;15(5):986-992. doi: 10.1177/1932296821997851. Epub 2021 Mar 14. J Diabetes Sci Technol. 2021. PMID: 33719622 Free PMC article.
-
Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?Diabet Med. 2020 Jul;37(7):1146-1154. doi: 10.1111/dme.14319. Epub 2020 May 29. Diabet Med. 2020. PMID: 32392380 Free PMC article.
-
Psychological distress and experiences of Adolescents and Young Adults with cancer during the COVID-19 pandemic: A cross-sectional survey.Psychooncology. 2022 Apr;31(4):631-640. doi: 10.1002/pon.5849. Epub 2022 Jan 5. Psychooncology. 2022. PMID: 34989053
-
Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies.Front Endocrinol (Lausanne). 2022 Mar 9;13:856958. doi: 10.3389/fendo.2022.856958. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35355556 Free PMC article.
-
COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.Expert Rev Endocrinol Metab. 2023 Mar;18(2):167-179. doi: 10.1080/17446651.2023.2176300. Epub 2023 Feb 16. Expert Rev Endocrinol Metab. 2023. PMID: 36797835 Review.
Cited by
-
Physical stimuli-responsive polymeric patches for healthcare.Bioact Mater. 2024 Sep 28;43:342-375. doi: 10.1016/j.bioactmat.2024.08.025. eCollection 2025 Jan. Bioact Mater. 2024. PMID: 39399837 Free PMC article. Review.
-
Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study.J Clin Med. 2024 Mar 26;13(7):1922. doi: 10.3390/jcm13071922. J Clin Med. 2024. PMID: 38610687 Free PMC article.
-
Network Analysis of Depressive Symptoms, Social Support, and Diabetes Distress Among Patients with Type 2 Diabetes: A Cross-Sectional Study.Patient Prefer Adherence. 2025 Jul 8;19:1951-1964. doi: 10.2147/PPA.S521735. eCollection 2025. Patient Prefer Adherence. 2025. PMID: 40661895 Free PMC article.
-
Trends of lower-limb complications in patients with type 2 diabetes mellitus during the COVID-19 pandemic.Diabetes Res Clin Pract. 2025 Aug;226:112331. doi: 10.1016/j.diabres.2025.112331. Epub 2025 Jun 19. Diabetes Res Clin Pract. 2025. PMID: 40543573
References
-
- van Bastelaar KMP, Pouwer F, Geelhoed-Duijvestijn PHLM, Tack CJ, Bazelmans E, Beekman AT, et al. Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in type 1 and type 2 diabetes. Diabet Med. 2010;27:798–803. doi: 10.1111/j.1464-5491.2010.03025.x. - DOI - PubMed
-
- Tsujii S, Hayashino Y, Ishii H, Diabetes Distress and Care Registry at Tenri Study Group Diabetes distress, but not depressive symptoms, is associated with glycaemic control among Japanese patients with type 2 diabetes: diabetes distress and Care Registry at Tenri (DDCRT 1) Diabet Med. 2012;29:1451–5. doi: 10.1111/j.1464-5491.2012.03647.x. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical